Skip to main content
. 2024 Jul 5;30(8):4867–4877. doi: 10.1111/odi.15009

TABLE 5.

Evaluation of web‐based tools to predict prognosis in OTSCC.

Web‐based tools Positive (%) Negative (%) Total Area under ROC curve (95% CI) p‐value Number and sensitivity (%) Number and Specificity (%) Accuracy (%)
Prediction of locoregional recurrence‐free survival
(A) Recurrence‐free survival a 57 (74.02) 20 (25.98) 77 0.691 (0.56–0.81) 0.011 9 (45) 45 (78.9) 70
(B) Recurrence‐free survival (Net benefit) 96 (71.11) 39 (28.89) 135 0.574 (0.46–0.68) 0.179 47 (49.0) 25 (64.1) 53
(B) Recurrence‐free survival (Surgery alone) 96 (71.11) 39 (28.89) 135 0.468 (0.36–0.57) 0.440 57 (59.4) 14 (35.9) 52
(B) Recurrence‐free survival (Surgery + RT) 96 (71.11) 39 (28.89) 135 0.508 (0.40–0.61) 0.949 52 (54.2) 14 (35.9) 48
Prediction of risk of recurrence
(E) Risk of locoregional recurrence b 58 10 (52.6) 8 (97.4) 82
Prediction of survival
(B) 5‐year survival OS 77 (57.03) 58 (42.97) 135 0.636 (0.54–0.72) 0.007 42 (54.5) 32 (55.2) 54
Prediction of cancer‐related mortality
(C) Years mean survival DSS 107 (79.25) 28 (20.75) 135 0.729 (0.62–0.83) <0.001 88 (82.2) 14 (50.0) 75
(C) 10‐year cancer mortality 28 (20.75) 107 (79.25) 135 0.858 (0.78–0.93) <0.001 23 (82.1) 81 (75.7) 77
(C) Kaplan–Meier death rate 28 (20.75) 107 (79.25) 135 0.765 (0.67–0.85) <0.001 23 (82.1) 77 (72.0) 74
(D) 5‐year survival rate DSS 107 (79.25) 28 (20.75) 135 0.723 (0.62–0.82) <0.001 84 (78.5) 17 (60.7) 74

Abbreviations: DSS, Disease‐specific survival; OS, Overall survival; RT, Radiotherapy.

a

77 cases were included as smoking status was unknown.

b

58 cases were included to exclude data used in our previous study/AUC curve was not feasible.